We were honored to screen and have a conversation about Swallow THIS: a Documentary film that explored methadone during the period of COVID-19 with the Greater Harlem Coalition (GHC) on Saturday, October 14th, in Harlem.
At the screening, several people asked if there is legislation to reform methadone clinics. Yes, it is called the Modernizing Opioid Treatment Access Act (MOTAA, HR 1359.) Reps. Donald Norcross (D-NJ) and Don Bacon (R-NE) are the bipartisan sponsors. The bill has been introduced in the US House of Representatives.
The MOTAA allows certain medical practitioners to prescribe methadone that is dispensed at a pharmacy, completely bypassing the brick-and-mortar clinic system. That sounds like a
significant change to the current system, but it is not.
We oppose the MOTAA for a number of reasons. The most important is the bill maintains racial disparities in access to medication for addiction. This is the cautionary tale of buprenorphine (another medication to treat opioid addiction.) Studies have shown for decades that buprenorphine, which can be prescribed by any health care provider and is picked up at the pharmacy, is overwhelmingly prescribed to white people. The MOTAA will do the exact same with methadone.